Addus Healthcare, Inc. (NASDAQ: ADUS) 15% LOWER; reports Q4 adjusted EPS of $0.07, versus the analyst estimate of $0.20.
Revenue for the quarter was $65.7 million, which compares to the estimate of $66.52 million. Palm (NASDAQ: PALM) 13.5% LOWER; reports Q3 adj-loss of $0.61, versus the analyst estimate of ($0.42).
Revenue for the quarter was $366 million, which compares to the estimate of $316.19 million. Shipped 960,000 smartphones during the quarter.
Sees Q4 sales of about $150 million, which compares...
Post new comment